Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,999 | Dovepress* | 7,002+ | 934 | 7,936 | |
| PubMed Central* | 997 | 328 | 1,325 | ||
| Totals | 7,999 | 1,262 | 9,261 | ||
| *Since 14 November 2017 | |||||
View citations on PubMed Central and Google Scholar